Why Is GLOBE LIFE INC (GL) Stock Down Today?

Globe Life Inc. shares fell 6.48% to $157.50 following the release of third-quarter 2026 earnings. The primary driver of the decline was a downgrade from Piper Sandler, which cited concerns over medical claims, alongside a price target reduction by TD Cowen.

What Happened

Piper Sandler downgraded Globe Life to Neutral from Overweight and lowered its price target to $165, pointing to medical claims concerns. TD Cowen also adjusted its outlook, maintaining a Buy rating but cutting its price target from $225 to $215. The company reported adjusted earnings per share of $4.84, slightly below the estimated $4.88, while revenue reached $1.60 billion, up from $1.51 billion in the prior year. Management noted that premium revenue grew 7% despite headwinds in the health segment from CMS delays. Globe Life projects 2027 EPS of $16.10 to $17.10 and targets $850 million to $950 million in parent excess cash flow.

What The Data Shows

The stock opened at $167.30, a 0.7% gap down from the prior close of $168.41. It hit a session high of $167.65 at 7:20 AM ET before sliding to a low of $157.33 at 10:35 AM ET. Volume stood at 0.3 million shares, which is 0.5 times the three-month daily average. Fundamentals show a market cap of $13.0 billion, a P/E ratio of 11.3, and a dividend yield of 0.78%. The 52-week range is $127.84 to $191.55. On October 23, 2026, the stock printed one fresh 52-week high and 27 fresh 52-week lows. Recent insider activity includes six sales totaling $30.0 million over the last 90 days, with no buys recorded. The most recent sale was by Robert Edward Hensley on September 22, 2026.

What To Watch

Investors will monitor the company's ability to manage medical claims costs and the impact of CMS delays on its health segment. The upcoming earnings date is not specified in the provided data, but coverage from seven sources in the last 36 hours suggests continued analyst focus on the stock's valuation and guidance.